Haloperidol and reduced haloperidol plasma levels in Chinese vs. non-Chinese psychiatric patients

Michael W. Jann, Wen Ho Chang, Chester M. Davis, Teng Yi Chen, Hwei Chuang Deng, For Wei Lung, Larry Ereshefsky, Stephen R. Saklad, Ann L. Richards

    Research output: Contribution to journalArticlepeer-review

    43 Scopus citations


    Haloperidol and reduced haloperidol plasma concentrations were measured in age-matched Chinese and non-Chinese patients (n = 32). Steady-state plasma concentrations were obtained 10-12 hours after the bedtime dose. Haloperidol and reduced haloperidol concentrations were measured by liquid chromatography and radioimmunoassay. Haloperidol plasma concentrations did not significantly differ between the populations, but reduced haloperidol levels were 3 times greater in non-Chinese patients than in Chinese patients. The incidence of extrapyramidal side effects was higher in Chinese patients (18 vs. 10), while non-Chinese patients with extrapyramidal symptoms had higher reduced haloperidol plasma levels. Logistic regression analysis revealed that ethnicity and reduced haloperidol/haloperidol ratios were important variables in predicting extrapyramidal symptoms. These results suggest that the metabolism and disposition of haloperidol and reduced haloperidol could differ among ethnic populations.

    Original languageEnglish (US)
    Pages (from-to)45-52
    Number of pages8
    JournalPsychiatry Research
    Issue number1
    StatePublished - Oct 1989


    • Chinese
    • Haloperidol
    • plasma levels
    • reduced haloperidol
    • schizophrenia

    ASJC Scopus subject areas

    • Psychiatry and Mental health
    • Biological Psychiatry


    Dive into the research topics of 'Haloperidol and reduced haloperidol plasma levels in Chinese vs. non-Chinese psychiatric patients'. Together they form a unique fingerprint.

    Cite this